Keywords: Baxter Int, Gambro, Dialysis products, Medical technolkogy, M&A

Baxter to expand renal therapies range with $4 billion buy of Gambro

Article | 04 December 2012

Print This

Confirming recent rumors and speculation, Baxter International (NYSE:BAX ) said yesterday it has entered into a definitive agreement to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in